trastuzumab biosimilar / Stada, Gedeon Richter - LARVOL DELTA

Richter and DM Bio agreement on technology transfer and license-in of biosimilar Trastuzumab (Gedeon Richter Press Release) - "Gedeon Richter...today announces that it has signed a technology transfer and license-in agreement with DM Bio...in respect of the development and commercialization of DM Bio's biosimilar monoclonal antibody, Trastuzumab...Richter receives exclusive distribution rights for Europe, the CIS region and Latin American countries and it also obtains the pilot technology for further development."

Licensing / partnership • Biosimilar